# FDA Inspection 818049 - Carter BloodCare - Baylor - February 07, 2013

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare-baylor/a54747af-19bd-4e9b-9724-e987ff37e95f
Source feed: FDA_Inspections

> FDA Inspection 818049 for Carter BloodCare - Baylor on February 07, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 818049
- Company Name: Carter BloodCare - Baylor
- Inspection Date: 2013-02-07
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1237401 - 2024-04-26](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-baylor/59e68d83-891c-4124-9058-253a77919e1e)
- [FDA Inspection 1098356 - 2019-07-25](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-baylor/8c27a9f0-557c-400c-9909-7ccb807c1d1b)
- [FDA Inspection 927574 - 2015-05-20](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-baylor/14e83d08-2366-4bb3-b132-c9b998dd0ecc)
- [FDA Inspection 733844 - 2011-07-08](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-baylor/dbd411b4-fc2e-4549-bac1-bafdcbb58562)
- [FDA Inspection 631572 - 2009-12-02](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-baylor/e0bcdddd-81f1-4326-b082-47bc6fa4e188)

Company: https://www.keypedia.com/companies/carter-bloodcare-baylor/9fa47e8a-27d8-4c76-88d3-9c542be5fb6f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d